[
  {
    "ts": "2026-02-14T17:12:04+00:00",
    "headline": "Labcorp’s New Alzheimer’s Blood Test Might Change The Case For Investing In Labcorp Holdings (LH)",
    "summary": "In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying symptomatic patients aged 55+ who are unlikely to have amyloid pathology. This test broadens access to Alzheimer’s assessment through a simple blood draw, potentially easing specialist bottlenecks and shifting more initial evaluation into primary care. Next, we’ll examine how expanding Alzheimer’s blood...",
    "url": "https://finance.yahoo.com/news/labcorp-alzheimer-blood-test-might-171204964.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9bc5d0f3-31f3-31de-a18b-ad1aa9fb326a",
      "content": {
        "id": "9bc5d0f3-31f3-31de-a18b-ad1aa9fb326a",
        "contentType": "STORY",
        "title": "Labcorp’s New Alzheimer’s Blood Test Might Change The Case For Investing In Labcorp Holdings (LH)",
        "description": "",
        "summary": "In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying symptomatic patients aged 55+ who are unlikely to have amyloid pathology. This test broadens access to Alzheimer’s assessment through a simple blood draw, potentially easing specialist bottlenecks and shifting more initial evaluation into primary care. Next, we’ll examine how expanding Alzheimer’s blood...",
        "pubDate": "2026-02-14T17:12:04Z",
        "displayTime": "2026-02-14T17:12:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pUPV1p_Bw8ydOCyP5dgMaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLvgYYeIn3Dw6STv9CZZCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-alzheimer-blood-test-might-171204964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-alzheimer-blood-test-might-171204964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]